Pneumocystis jiroveci pneumonia in patients receiving ddAC for breast cancer: A single center retrospective study

Chika Manako, Rikiya Nakamura, Satoshi Yoshimura, Tamaki Tamanuki, Shouko Hayama, Toshiko Miyaki, Keiko Oshida, Masaki Oshida, Yasushi Ito, Hideki Tsujimura,Kyoya Kumagai, Naohito Yamamoto

Annals of Oncology（2023）

引用 0|浏览1

暂无评分

摘要

Since the introduction of dose dense regimens, we observed an increase in Pneumocystis jiroveci Pneumonia (PCP) incidence in cases treated with dose dense Adriamycin/Cyclophosphamide (ddAC) regimen for adjuvant or neoadjuvant chemotherapy in our institution. We identified the incidence of PCP in this population and evaluated risk factors.

查看译文

关键词

pneumocystis jiroveci pneumonia,breast cancer,ddac

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要